Available clinical evidence regarding L-carnitine supplementation in MASLD is summarized in Table 2, highlighting both reported metabolic benefits and the current limitations and heterogeneity of human studies
De este modo, ayuda a mejorar el rendimiento fsico, aumenta la resistencia y favorece la utilizacin de las grasas como combustible durante el ejercicio
Abel ED, Gloyn AL, Evans-Molina C, Joseph JJ, Misra S, Pajvani UB, Simcox J, Susztak K, Drucker DJ
In patients with coexisting obesity and risky drinking patterns, GLP1 therapy has been associated with modest decreases in alcohol intake alongside weight loss
The animal protocol was approved by the Animal Care and Use Committee of the University of Colorado, Denver